Recent Publications in Refereed Journals (2003-Present):
Seftor REB, Seftor EA, Hess AR and Hendrix MJC. 2003. The role of the vasculogenic phenotype and its associated extracellular matrix in tumor progression: Implications for immune surveillance. Clin Applied Immunol Rev 3:263-276.
Hendrix MJC, Seftor EA, Hess AR and Seftor REB. 2003. The molecular plasticity of human melanoma cells. Oncogene Rev 22:3070-3075.
Hendrix MJC, Seftor EA, Hess AR and Seftor REB. 2003. Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma. Nature Rev Cancer 3:411-421.
Hendrix MJC, Seftor EA, Kirschmann DA, Quaranta V and Seftor REB. 2003. Remodeling the microenvironment by aggressive melanoma tumor cells. Annals NY Acad Sci 995:151-161.
Odero-Marah V, Khalkhali-Ellis Z, Seftor EA, Seftor REB and Hendrix MJC. 2003. Maspin regulates cell motility through the RAC signaling pathway. Cancer Biol & Therapy 2:67-72.
Hess AR, Seftor EA, Seftor REB and Hendrix MJC. 2003. Phosphoinositide 3-kinase regulates membrane type-1 matrix metalloproteinase (MT1-MMP) and MMP-2 activity during melanoma cell vasculogenic mimcry. Cancer Res. 63:4757-4762.
Ruf W, Seftor EA, Prtrovan R, Weiss RM, Gruman LM, Margaryan NV, Seftor REB, Miyagi Y and Hendrix MJC. 2003. Differential role of tissue factor pathway inhibitors-1 and 2 (TFPI-1 and 2) in melanoma vasculogenic mimicry. Cancer Res 63:5381-5389.
Chunthapong J, Seftor EA, Khalkhali-Ellis Z, Seftor REB, Amir S, Lubaroff DM, Heidger PM Jr. and Hendrix MJC. 2004. Dual roles of E-cadherin in prostate cancer invasion. J Cell Biochem 91:649-661.